Analysis of Chronic Tonsillitis: A Case Study
Lina Marlina, Joao C.H.A Barreto, Fransiskus Harf Poluan
Asian Journal of Advanced Research and Reports · pp. 301–310 · Published 15 Mar 2025
10.9734/ajarr/2025/v19i3943Abstract
Background: Tonsillitis is the third most infectious ear, nose, and throat disease after rhinopharyngitis and otitis. Tonsillitis can have local or general complications. Tonsillitis is a health problem in society because of its incidence, frequency, and many socioeconomic impacts. Tonsillitis and its complications are important pathologies in ENT. Tonsillitis occurs in most cases in children and young adults, especially between the ages of 20 and 30 years, with a slight predominance in women. Case Report: The patient is a 20-year-old female who came to the ENT Polyclinic at Jakarta Harbor Hospital complaining of difficulty swallowing for two months. Complaints are felt continuously, such as discomfort when swallowing, increased difficulty swallowing, pain when swallowing, and decreased appetite. Complaints worsen and recur when the patient drinks cold drinks such as ice. The patient complained that he was often restless while sleeping, so the patient often woke up at night. Patients complain that they often experience shortness of breath and are more comfortable when breathing through their mouths. Complaints of fever were felt to have been intermittent for the previous two months, the last fever was two days before his arrival at the polyclinic with a measured temperature of 38.9℃. Fever occurs two times a week. The patient recovered and was stable after treatment in the form of analgesic therapy through the administration of ibuprofen or paracetamol, corticosteroid therapy through administration of a dose of corticosteroid as an anti-inflammatory, 3x1 prednisone tablet for three days, mouthwash therapy via antiseptic mouthwash containing chlorhexidine or benzydamine can reduce complaints of sore throat and improve symptoms; antibiotic therapy by administering oral Amoxicillin 50 mg/kg BW once a day or 25 mg/kg BW twice a day for ten days, first-generation cephalosporins such as cephalexin (orally 20 mg/kg BW twice a day) and cefadroxil (orally 30 mg/kg BW once a day) given for ten days, Clindamycin orally 7mg/kg BW, three times a day, Azithromycin orally 12 mg/kg BW once a day, Oral clarithromycin 7.5 mg/kg BW two times a day.
Cited by 0
No indexed citations yet.
Related research
- Pattern of Hearing Impairment in a Tertiary Institution in Ado Ekiti, Nigeria — shares topic coverage
- Weight Gain as Tuberculosis Treatment Regimen Progresses in Patients Receiving Antituberculosis Therapy — shares topic coverage
- TREAT-B has Good Accuracy in Selecting HBV Infected Patients for Treatment in Sudan — shares topic coverage
- Botox Treatment: A Comprehensive Review — shares topic coverage
- Harnessing Artificial Intelligence in Healthcare Analytics: From Diagnosis to Treatment Optimization — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.